1-13 of 13
Samir Agrawal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production

Free
John C. Riches, Jeffrey K. Davies, Fabienne McClanahan, Rewas Fatah, Sameena Iqbal, Samir Agrawal, Alan G. Ramsay, John G. Gribben
Journal: Blood
Blood (2013) 121 (9): 1612–1621.
https://doi.org/10.1182/blood-2012-09-457531
Published: 2013
Includes: Supplemental data
Journal Articles

Drp1 Activation Overcomes Diffuse Large B-Cell Lymphoma Cells Radioresistance

Free
Qingsong Pang, Sr., Ningbo Liu, Sr., Fengting Liu, Samir Agrawal, Ping Wang, Sr.
Journal: Blood
Blood (2012) 120 (21): 5121.
https://doi.org/10.1182/blood.V120.21.5121.5121
Published: 2012
Journal Articles

Characterizing Immunophenotypic and Functional Pseudo-Exhaustion in T Cells From CLL Patients: The Impact of Lenalidomide

Free
John C. Riches, MD, Jeff K. Davies, MD, PhD, Fabienne McClanahan, Rewas Fatah, Sameena Iqbal, Samir Agrawal, Alan G. Ramsay, PhD, John G Gribben
Journal: Blood
Blood (2012) 120 (21): 564.
https://doi.org/10.1182/blood.V120.21.564.564
Published: 2012
Journal Articles

Early Detection of Minimal Residual Disease in Biological Prognostic Risk Groups in Chronic Lymphocytic Leukaemia (CLL) Utilizing the Novel CD160FCA Assay

Free
Timothy W Farren, Fengting Liu, Marion Macey, Michael Jenner, MD, PhD, FRCPath, Samir Agrawal
Journal: Blood
Blood (2011) 118 (21): 2832.
https://doi.org/10.1182/blood.V118.21.2832.2832
Published: 2011
Journal Articles

The Prognostic Significance of Monoallelic Versus Biallelic 13q Deletions in Patients with Chronic Lymphocytic Leukemia,

Free
Smita Sinha, Timothy W Farren, Marianne Grantham, Samir Agrawal
Journal: Blood
Blood (2011) 118 (21): 3893.
https://doi.org/10.1182/blood.V118.21.3893.3893
Published: 2011
Journal Articles

T-Cells From Patients with CLL Exhibit Phenotypic and Transcription Factor Profiles of Exhaustion Independent of CMV Serostatus

Free
John C. Riches, MD, Jeff Davies, MD, PhD, Sameena Iqbal, Rewas Fatah, Samir Agrawal, Alan G. Ramsay, PhD, John G. Gribben, MD, DSc
Journal: Blood
Blood (2011) 118 (21): 1780.
https://doi.org/10.1182/blood.V118.21.1780.1780
Published: 2011
Journal Articles

Autocrine IL6/STAT3 Signaling Enhances Survival of Chronic Lymphocytic Leukaemia Cells

Free
Fengting Liu, MD, PhD, Li Jia, MD, PhD, Timothy Farren, BSc(HONS), MIBMS, John G. Gribben, MD, DSc, Samir Agrawal, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3598.
https://doi.org/10.1182/blood.V116.21.3598.3598
Published: 2010
Journal Articles

Inter-Laboratory Assessment of Minimal Residual Disease In Chronic Lymphocytic Leukemia – Evaluation of the Novel CD160FCA Assay

Free
Timothy Farren, BSc(HONS), MIBMS, Fengting Liu, MD, PhD, Claire Stephens, MSc, Marion Macey, PhD, FRCPath, Michael Jenner, MD, PhD, FRCPath, Archie Prentice, MB, FRCP, FRCPath, Amit Nathwani, MBChB, FRCP, FRCPath, Samir Agrawal, MD, PhD, FRCPath
Journal: Blood
Blood (2010) 116 (21): 2723.
https://doi.org/10.1182/blood.V116.21.2723.2723
Published: 2010
Journal Articles

Using CD160 as a Novel Approach to the Assessment of Minimal Residual Disease (MRD) in Chronic Lymphocytic Leukaemia (CLL).

Free
Timothy Farren, BSc (Hons), Jerome Giustiniani, PhD, Ulrika Johansson, PhD, Christina Lim, RN, Gemma Athorn, MSc, Adrian Newland, MD, Marion Macey, PhD, Samir Agrawal, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2036.
https://doi.org/10.1182/blood.V110.11.2036.2036
Published: 2007
Journal Articles

High Frequency of Surface Immunoglobulin IgG in B-Cell Chronic Lymphocytic Leukaemia.

Free
Catherine Wiseman, BSc, Jerome Giustiniani, PhD, Lene Mikkelsen, MSc, Marion Macey, PhD, Lindsey Goff, PhD, John Gribben, MD, PhD, Samir Agrawal, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4685.
https://doi.org/10.1182/blood.V110.11.4685.4685
Published: 2007
Journal Articles

Reduced Dose PAD Combination Therapy (PS-341/Bortezomib, Adriamycin and Dexamethasone) for Previously Untreated Patients with Multiple Myeloma.

Free
Rakesh Popat, MBBS, Heather E. Oakervee, MRCPath, Nicola Curry, MBBS, Nicola Foot, BSc, Curly Morris, FRCP, Mary Drake, MRCPath, Samir Agrawal, PhD, Patricia Smith, RGN, David Schenkein, MD, Dixie-Lee Esseltine, MD, Jamie D. Cavenagh, MD
Journal: Blood
Blood (2005) 106 (11): 2554.
https://doi.org/10.1182/blood.V106.11.2554.2554
Published: 2005
Journal Articles

A Phase I/II Study of Bortezomib and Low Dose Intravenous Melphalan (BM) for Relapsed Multiple Myeloma.

Free
Rakesh Popat, DipRCPath, Heather E. Oakervee, MRCPath, Nicola Foot, BSc, Samir Agrawal, PhD, Patricia Smith, RGN, Charles Craddock, FRCPath, Catherine Williams, FRCPath, Supratik Basu, FRCPath, Jamie D. Cavenagh, MD
Journal: Blood
Blood (2005) 106 (11): 2555.
https://doi.org/10.1182/blood.V106.11.2555.2555
Published: 2005
Journal Articles

PAD Combination Therapy (PS-341/Bortezomib, Adriamycin and Dexamethasone) for Previously Untreated Patients with Multiple Myeloma.

Free
James D. Cavenagh, MD, Rakesh Popat, MB BS, Nikki Curry, MB BS, Jim Stec, PhD, Treen C. Morris, FRCP, Mary Drake, MRCPath, Samir Agrawal, PhD, Patricia Smith, RGN, David P. Schenkein, MD, Dixie-Lee Esseltine, MD, Heather Oakervee, MRCP
Journal: Blood
Blood (2004) 104 (11): 1478.
https://doi.org/10.1182/blood.V104.11.1478.1478
Published: 2004